Twelve percent of nearly 3,000 norovirus tests during the week ending Nov. 22 came back positive — a notable increase from the 6.82% positivity rate three months earlier, according to CDC data.
During the week ending Aug. 23, 6.82% of 4,034 norovirus tests were positive. A CDC system that tracks viral activity in the U.S. shows a 12% positivity rate among 2,825 norovirus tests, as of Nov. 22, the most recent data available.
This near-double increase in percent positive norovirus tests is occurring at the same time activity for whooping cough and influenza is also increasing. Last December, the CDC’s viral activity dashboard recorded a 24.82% positivity rate in one week’s norovirus tests. The 2024-25 respiratory virus season acutely affected hospitals as infection rates of COVID-19, flu and respiratory syncytial virus rose while norovirus surged to a decade-high.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
